Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Cell-free DNA Quantification With Fluorescent Assay in Response Evaluation of Palliative Chemotherapy

NCT05227950 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.

NCT NCT05227950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Cell-free DNA Quantification With Fluorescent Assay in Response Evaluation of Palliative Chemotherapy
Lead sponsor
Pusan National University Yangsan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
June 30, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, cell-free nucleic acids, fluorescence, palliative chemotherapy